Neuren Pharmaceuticals Ltd
ASX:NEU

Watchlist Manager
Neuren Pharmaceuticals Ltd Logo
Neuren Pharmaceuticals Ltd
ASX:NEU
Watchlist
Price: 20.72 AUD -1.15% Market Closed
Updated: May 31, 2024

Neuren Pharmaceuticals Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Neuren Pharmaceuticals Ltd
Cash from Financing Activities Peer Comparison

Comparables:
MYX
BOT
PBP
C
CU6
VLS

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Neuren Pharmaceuticals Ltd
ASX:NEU
Cash from Financing Activities
AU$3.6m
CAGR 3-Years
-43%
CAGR 5-Years
-21%
CAGR 10-Years
-18%
Mayne Pharma Group Ltd
ASX:MYX
Cash from Financing Activities
-AU$431.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Botanix Pharmaceuticals Ltd
ASX:BOT
Cash from Financing Activities
AU$36.2m
CAGR 3-Years
N/A
CAGR 5-Years
11%
CAGR 10-Years
46%
Probiotec Ltd
ASX:PBP
Cash from Financing Activities
-AU$11.1m
CAGR 3-Years
N/A
CAGR 5-Years
-1%
CAGR 10-Years
0%
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Cash from Financing Activities
AU$231.6k
CAGR 3-Years
-70%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vita Life Sciences Ltd
ASX:VLS
Cash from Financing Activities
-AU$2.9m
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
-15%

See Also

What is Neuren Pharmaceuticals Ltd's Cash from Financing Activities?
Cash from Financing Activities
3.6m AUD

Based on the financial report for Dec 31, 2023, Neuren Pharmaceuticals Ltd's Cash from Financing Activities amounts to 3.6m AUD.

What is Neuren Pharmaceuticals Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-18%

The average annual Cash from Financing Activities growth rates for Neuren Pharmaceuticals Ltd have been -43% over the past three years , -21% over the past five years , and -18% over the past ten years .